Improved Survival of Lymphoma Patients with COVID-19 in the Modern Treatment and Vaccination Era

SIMPLE SUMMARY: Patients with lymphoma are at greater risk of complications from COVID-19 infection. However, limited data exists on COVID-19-related outcomes in lymphoma patients since the use of COVID-19 vaccines and treatments began. Our study reports the real-world outcomes of 68 lymphoma or CLL...

Descripción completa

Detalles Bibliográficos
Autores principales: Della Pia, Alexandra, Zhao, Charles, Jandir, Parul, Gupta, Amolika, Batistick, Mark, Kim, Gee Youn (Geeny), Xia, Yi, Ahn, Jaeil, Magarelli, Gabriella, Lukasik, Brittany, Leslie, Lori A., Goy, Andre H., Ip, Andrew, Feldman, Tatyana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454633/
https://www.ncbi.nlm.nih.gov/pubmed/36077782
http://dx.doi.org/10.3390/cancers14174252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454633/
https://www.ncbi.nlm.nih.gov/pubmed/36077782
http://dx.doi.org/10.3390/cancers14174252

Ejemplares similares